DAN (NBL1) specifically antagonizes BMP2 and BMP4 and modulates the actions of GDF9, BMP2, and BMP4 in the rat ovary1

Biology of Reproduction

Volumn 86, Issue 5, 2012, Pages

  Hung, Wei Ting ^a   Wu, Fang Ju ^a   Wang, Chun Jen ^a   Luo, Ching Wei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

BMP antagonist; BMP4; DAN; GDF9; Ovary

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GONADOTROPIN; GROWTH DIFFERENTIATION FACTOR 9; PROGESTERONE; RECOMBINANT CYTOKINE; RECOMBINANT DIFFERENTIAL SCREENING SELECTED GENE ABERRATIVE IN NEUROBLASTOMA PROTEIN; UNCLASSIFIED DRUG; NBL1 PROTEIN, HUMAN; NBL1 PROTEIN, RAT; NERVE PROTEIN; PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; FEMALE; GRANULOSA CELL; MICRODISSECTION; NONHUMAN; OVARY; OVARY CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL STRAIN 3T3; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOUSE;

RATTUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; GONADOTROPINS; GROWTH DIFFERENTIATION FACTOR 9; HUMANS; MICE; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; OVARY; PROTEINS; RATS;

EID: 84864001079     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.096172     Document Type: Article

References (30)

1. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. Bone morphogenetic proteins: a critical review. Cell Signal 2011; 23:609-620.
2. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22:233-241.
3. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002; 23: 787-823
4. Mazerbourg S, Sangkuhl K, Luo CW, Sudo S, Klein C, Hsueh AJ. Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem 2005; 280:32122-32132.
5. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006; 132:191-206.
6. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 2004; 25:72-101
7. Avsian-Kretchmer O, Hsueh AJ. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol Endocrinol 2004; 18:1-12.
8. Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 2003; 24:218-235.
9. Vitt UA, Hsu SY, Hsueh AJ. Evolution and classification of cystine knotcontaining hormones and related extracellular signaling molecules. Mol Endocrinol 2001; 15:681-694.
10. Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, Takahashi H, Ohnuma N, Tanabe M, Iwai J, Yoshida H, Matsunaga T, Sakiyama S. Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene 1994; 9:2785-2791
11. Ozaki T, Sakiyama S. Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts. Proc Natl Acad Sci U S A 1993; 90:2593-2597.
12. Stanley E, Biben C, Kotecha S, Fabri L, Tajbakhsh S, Wang CC, Hatzistavrou T, Roberts B, Drinkwater C, Lah M, Buckingham M, Hilton D, et al. DAN is a secreted glycoprotein related to Xenopus cerberus. Mech Dev 1998; 77:173-184.
13. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998; 1:673-683.
14. Dionne MS, Skarnes WC, Harland RM. Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor beta antagonists. Mol Cell Biol 2001; 21:636-643.
15. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 2002; 277: 4883-4891.
16. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998; 17:3091-3100.
17. Luo CW, Kawamura K, Klein C, Hsueh AJ. Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors. Mol Endocrinol 2004; 18:2085-2096.
18. Luo CW, Pisarska MD, Hsueh AJ. Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary. Endocrinology 2005; 146:469-476.
19. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci U S A 1999; 96:7282-7287.
20. Lin SJ, Lerch TF, Cook RW, Jardetzky TS, Woodruff TK. The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction 2006; 132:179-190.
21. Thompson TB, Woodruff TK, Jardetzky TS. Structures of an ActRIIB: activin A complex reveal a novel binding mode for TGF-beta ligand: receptor interactions. EMBO J 2003; 22:1555-1566.
22. Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormoneinduced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 2000; 62:370-377.
23. Souza CJ, Campbell BK, McNeilly AS, Baird DT. Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction 2002; 123:363-369.
24. Glister C, Richards SL, Knight PG. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology 2005; 146:1883-1892.
25. Brankin V, Quinn RL, Webb R, Hunter MG. BMP-2 and -6 modulate porcine theca cell function alone and co-cultured with granulosa cells. Domest Anim Endocrinol 2005; 29:593-604.
26. Pangas SA, Jorgez CJ, Matzuk MM. Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin. J Biol Chem 2004; 279:32281-32286.
27. Sudo S, Avsian-Kretchmer O, Wang LS, Hsueh AJ. Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation. J Biol Chem 2004; 279: 23134-23141
28. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 2004; 18:953-967
29. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 2004; 127:239-254
30. Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M. Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 2011; 116:3677-3680